Tilal Elsaman - Search Results

Year	Number of Results
2011	2
2012	1
2013	2
2015	1
2016	1
2017	1
2018	1
2019	3
2020	2
2021	3
2022	4
2023	2
2024	2

1

Ginsenoside Rg5 as an anticancer drug: a comprehensive review on mechanisms, structure-activity relationship, and prospects for clinical advancement.

Elsaman T, Muddathir AM, Mohieldin EAM, Batubara I, Rahminiwati M, Yamauchi K, Mohamed MA, Asoka SF, Büsselberg D, Habtemariam S, Sharifi-Rad J. Elsaman T, et al. Pharmacol Rep. 2024 Apr;76(2):287-306. doi: 10.1007/s43440-024-00586-5. Epub 2024 Mar 25. Pharmacol Rep. 2024. PMID: 38526651 Review.

2

Flavonostilbenes natural hybrids from Rhamnoneuron balansae as potential antitumors targeting ALDH1A1: molecular docking, ADMET, MM-GBSA calculations and molecular dynamics studies.

Elsaman T, Ahmad I, Eltayib EM, Suliman Mohamed M, Yusuf O, Saeed M, Patel H, Mohamed MA. Elsaman T, et al. J Biomol Struct Dyn. 2024 Apr;42(6):3249-3266. doi: 10.1080/07391102.2023.2218936. Epub 2023 Jun 1. J Biomol Struct Dyn. 2024. PMID: 37261483

3

A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis.

Mohamed MS, Mohamed AO, Alenazy R, Khan YH, Idriss MT, Alhudaib NAA, Elsaman T, Mohamed MA, Eltayib EM, Mallhi TH. Mohamed MS, et al. Among authors: elsaman t. Vaccines (Basel). 2023 Jan 31;11(2):315. doi: 10.3390/vaccines11020315. Vaccines (Basel). 2023. PMID: 36851192 Free PMC article.

4

Discovery of novel natural products as dual MNK/PIM inhibitors for acute myeloid leukemia treatment: Pharmacophore modeling, molecular docking, and molecular dynamics studies.

Mohamed LM, Eltigani MM, Abdallah MH, Ghaboosh H, Bin Jardan YA, Yusuf O, Elsaman T, Mohamed MA, Alzain AA. Mohamed LM, et al. Among authors: elsaman t. Front Chem. 2022 Jul 22;10:975191. doi: 10.3389/fchem.2022.975191. eCollection 2022. Front Chem. 2022. PMID: 35936081 Free PMC article.

5

Synthesis, Characterization, Functionalization and Bio-Applications of Hydroxyapatite Nanomaterials: An Overview.

Munir MU, Salman S, Ihsan A, Elsaman T. Munir MU, et al. Among authors: elsaman t. Int J Nanomedicine. 2022 May 2;17:1903-1925. doi: 10.2147/IJN.S360670. eCollection 2022. Int J Nanomedicine. 2022. PMID: 35530974 Free PMC article. Review.

6

De novo design of novel spike glycoprotein inhibitors using e-pharmacophore modeling, molecular hybridization, ADMET, quantum mechanics and molecular dynamics studies for COVID-19.

A Alzain A, Ismail A, Fadlelmola M, A Mohamed M, Mahjoub M, A Makki A, Elsaman T. A Alzain A, et al. Among authors: elsaman t. Pak J Pharm Sci. 2022 Jan;35(1(Supplementary)):313-321. Pak J Pharm Sci. 2022. PMID: 35228193

7

Isatin derivatives as broad-spectrum antiviral agents: the current landscape.

Elsaman T, Mohamed MS, Eltayib EM, Abdel-Aziz HA, Abdalla AE, Munir MU, Mohamed MA. Elsaman T, et al. Med Chem Res. 2022;31(2):244-273. doi: 10.1007/s00044-021-02832-4. Epub 2022 Jan 13. Med Chem Res. 2022. PMID: 35039740 Free PMC article. Review.

8

REVIEW- Covid-19: Diagnosis, summary of essays and evolving approaches.

Munir MU, Salman S, Ahmed A, Iqbal W, Abbas Bukhari SN, Ahmad N, Ullah MI, Masood Ahmad M, Elsaman T, Ali Tahir M. Munir MU, et al. Among authors: elsaman t. Pak J Pharm Sci. 2021 Sep;34(5):1813-1820. Pak J Pharm Sci. 2021. PMID: 34803020 Review.

9

Insight into the emerging role of SARS-CoV-2 nonstructural and accessory proteins in modulation of multiple mechanisms of host innate defense.

Abdalla AE, Xie J, Junaid K, Younas S, Elsaman T, Abosalif KOA, Alameen AAM, Mahjoob MO, Elamir MYM, Ejaz H. Abdalla AE, et al. Among authors: elsaman t. Bosn J Basic Med Sci. 2021 Oct 1;21(5):515-527. doi: 10.17305/bjbms.2020.5543. Bosn J Basic Med Sci. 2021. PMID: 33714258 Free PMC article. Review.

10

Formulation of amorphous ternary solid dispersions of dapagliflozin using PEG 6000 and Poloxamer 188: solid-state characterization, ex vivo study, and molecular simulation assessment.

Alruwaili NK, Zafar A, Imam SS, Alharbi KS, Alshehri S, Elsaman T, Alomar FA, Akhtar S, Fahmy UA, Alhakamy NA, Alshammari MS. Alruwaili NK, et al. Among authors: elsaman t. Drug Dev Ind Pharm. 2020 Sep;46(9):1458-1467. doi: 10.1080/03639045.2020.1802482. Epub 2020 Aug 5. Drug Dev Ind Pharm. 2020. PMID: 32729728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year